Formula & Concentration

(emicizumab-kxwh)

Manufacturer

Genentech Inc

Indications

HEMLIBRA is a bispecific factor IXa- and factor X-directed antibody indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A (congenital factor VIII deficiency) with factor VIII inhibitors. (1)

Product Options

Vial Size NDC
30 mg 50242-0920-01
60 mg 50242-0921-01
105 mg 50242-0922-01
150 mg 50242-0923-01

Shelf Life & Storage

24 months

Store HEMLIBRA vials in a refrigerator at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. Do not freeze. Do not shake. Prior to administration, if needed, unopened vials of HEMLIBRA may be stored out of and then returned to refrigeration. The temperature and total combined time out of refrigeration should not exceed 30°C (86°F) and 7 days (at a temperature below 30°C [86°F]), respectively. Once removed from the vial, discard HEMLIBRA if not used immediately. Discard any unused HEMLIBRA.

See full prescribing information for Hemlibra

Hemlibra

To order, call

855-307-6880

or fax
602-850-6226
or email
canyoncarerx@canyoncarerx.com

Can't find what you are looking for?

Please call us and we would love to help.

855-307-6880